These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25350589)

  • 1. Revealing the inherent heterogeneity of human malignancies by variant consensus strategies coupled with cancer clonal analysis.
    Peterson EA; Chavan SS; Bauer MA; Heuck CJ; Johann DJ
    BMC Bioinformatics; 2014; 15 Suppl 11(Suppl 11):S9. PubMed ID: 25350589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution.
    Miller CA; White BS; Dees ND; Griffith M; Welch JS; Griffith OL; Vij R; Tomasson MH; Graubert TA; Walter MJ; Ellis MJ; Schierding W; DiPersio JF; Ley TJ; Mardis ER; Wilson RK; Ding L
    PLoS Comput Biol; 2014 Aug; 10(8):e1003665. PubMed ID: 25102416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal evolution in cancer.
    Greaves M; Maley CC
    Nature; 2012 Jan; 481(7381):306-13. PubMed ID: 22258609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adapting clinical paradigms to the challenges of cancer clonal evolution.
    Murugaesu N; Chew SK; Swanton C
    Am J Pathol; 2013 Jun; 182(6):1962-71. PubMed ID: 23708210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonality Inference from Single Tumor Samples Using Low-Coverage Sequence Data.
    Donmez N; Malikic S; Wyatt AW; Gleave ME; Collins CC; Sahinalp SC
    J Comput Biol; 2017 Jun; 24(6):515-523. PubMed ID: 28056180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural and Chemotherapy-Induced Clonal Evolution of Tumors.
    Ibragimova MK; Tsyganov MM; Litviakov NV
    Biochemistry (Mosc); 2017 Apr; 82(4):413-425. PubMed ID: 28371598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer - An Insurgency of Clones.
    Gisselsson D; Egnell R
    Trends Cancer; 2017 Feb; 3(2):73-75. PubMed ID: 28718446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ClonArch: visualizing the spatial clonal architecture of tumors.
    Wu J; El-Kebir M
    Bioinformatics; 2020 Jul; 36(Suppl_1):i161-i168. PubMed ID: 32657368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-Evaluating Clonal Dominance in Cancer Evolution.
    Burrell RA; Swanton C
    Trends Cancer; 2016 May; 2(5):263-276. PubMed ID: 28741512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic analysis of tumor clonality.
    Teixeira MR; Heim S
    Adv Cancer Res; 2011; 112():127-49. PubMed ID: 21925303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing intratumor heterogeneity and tracking longitudinal and spatial clonal evolutionary history by next-generation sequencing.
    Jiang Y; Qiu Y; Minn AJ; Zhang NR
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5528-37. PubMed ID: 27573852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer systems biology in the genome sequencing era: part 2, evolutionary dynamics of tumor clonal networks and drug resistance.
    Wang E; Zou J; Zaman N; Beitel LK; Trifiro M; Paliouras M
    Semin Cancer Biol; 2013 Aug; 23(4):286-92. PubMed ID: 23792107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intraclonal heterogeneity in tumors and its impact on precision medicine].
    Roux J; Gouzé JL; Hofman P
    Med Sci (Paris); 2015 Jan; 31(1):28-31. PubMed ID: 25658727
    [No Abstract]   [Full Text] [Related]  

  • 14. CLImAT-HET: detecting subclonal copy number alterations and loss of heterozygosity in heterogeneous tumor samples from whole-genome sequencing data.
    Yu Z; Li A; Wang M
    BMC Med Genomics; 2017 Mar; 10(1):15. PubMed ID: 28298214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal evolution and tumor-initiating cells: New dimensions in cancer patient treatment.
    Apostoli AJ; Ailles L
    Crit Rev Clin Lab Sci; 2016; 53(1):40-51. PubMed ID: 26397062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal interactions in cancer: Integrating quantitative models with experimental and clinical data.
    Lee ND; Kaveh K; Bozic I
    Semin Cancer Biol; 2023 Jul; 92():61-73. PubMed ID: 37023969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumor diversity and clonal evolution in cancer--a skeptical standpoint.
    Gisselsson D
    Adv Cancer Res; 2011; 112():1-9. PubMed ID: 21925299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor clonality: research and clinical aspects.
    Nemtsova MV; Kushlinskii NE
    Bull Exp Biol Med; 2014 Dec; 158(2):246-51. PubMed ID: 25432282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer heterogeneity: converting a limitation into a source of biologic information.
    Rübben A; Araujo A
    J Transl Med; 2017 Sep; 15(1):190. PubMed ID: 28886708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model for cancer tissue heterogeneity.
    Mohanty AK; Datta A; Venkatraj V
    IEEE Trans Biomed Eng; 2014 Mar; 61(3):966-74. PubMed ID: 24557698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.